Noventra Pharma PT-141 (Bremelanotide 10mg Prefilled Pen)

PT-141 (Bremelanotide) is a synthetic peptide supplied in a pre-reconstituted pen format for controlled dispensing. It is classified as a melanocortin receptor agonist and is investigated for its interaction with central nervous system signalling pathways.

Bremelanotide has been studied in clinical and experimental contexts for its activity at melanocortin receptors involved in neuroendocrine and behavioural signalling processes.

Key Features:

• 10mg Bremelanotide (PT-141) per prefilled pen

• Melanocortin receptor agonist (MC receptor activity)

• Prefilled pen format for controlled and consistent application

• Investigated for interaction with central nervous system signalling pathways

• Studied in relation to neuroendocrine and behavioural regulatory processes

• Associated in research with melanocortin-related physiological pathways

Suggested Use:
For use under the guidance of a qualified professional. Protocols vary depending on application and individual requirements.

Storage:

• Store at 2–8°C at all times (refrigerated)

• Do not freeze

• Protect from light

• Avoid repeated temperature fluctuations

• Use within a limited timeframe once in use (based on formulation stability)

Important Information:
Bremelanotide has been studied in clinical settings for specific indications; however, this product should be used within appropriate professional and regulatory frameworks. Not recommended for individuals under 18, pregnant or breastfeeding individuals, or those with certain medical conditions. Ensure compliance with applicable regulations prior to use.